Erica Chong, a partner in Orrick’s Hong Kong office, is a member of the Complex Litigation and Dispute Resolution Group. She is a commercial litigator with 10-year experience in complex commercial disputes, international arbitration, corporate investigation and employment matters.

Her expertise includes advising international and regional clients on high-value commercial disputes arising from breach of contract, employment, negligence, breach of fiduciary duty and business torts, cross-border fraud and asset tracing claims, and insolvency, professional negligence, product liability, corporate compliance and antitrust issues. She also has significant experience in enforcement actions, arbitrations under the HKIAC, UNCITRAL and ICC Rules, as well as FCPA and SFC investigations.

Erica serves as Secretary to the Committee on Arbitration and ADR of the International Chamber of Commerce (ICC) - Hong Kong and is ICC Young Arbitrators Forum’s Regional Representative for North Asia.
  • International Arbitration
    • Acted for the founders of a leading service provider in the financial services industry in an HKIAC arbitration arising out of a sale of business to a French listed global solutions provider.
    • Acted for a New York-based investment management firm in an HKIAC arbitration against a Hong Kong-listed real estate developer, obtained an interim award ordering payment of US$164 million into an escrow account and achieved a US$200 million settlement through subsequent mediation.
    • Acted for a consortium of private equity investors in an UNCITRAL arbitration against a Chinese real estate developer, and obtained a final award ordering the adverse party to pay more than US$595 million.
    Commercial Litigation
    • Acting for a Fortune 500 multinational pharmaceutical and healthcare company and its subsidiaries in a high-profile product liability and personal injury matter.
    • Acted for a major PRC beverage manufacturer in a breach of contract claim in a U.S. District Court and achieved a settlement through mediation.
    • Acted for a Hong Kong-listed technology conglomerate on a US$2.8 billion multi-jurisdiction asset recovery exercise, including seeking Norwich Pharmacal relief and enforcing foreign judgments.
    • Acted for a Hong Kong-listed PRC manufacturer in high-profile trade secrets litigation in Hong Kong.
    • Acted for a Taiwanese client in challenging the jurisdiction of the Hong Kong court in claims relating to breach of fiduciary duty and constructive trust.
    • Acted for various companies in asset tracing and in seeking recovery of defrauded funds as a result of e-mail compromise scams.
    Compliance Investigations and Corporate Governance
    • Advised Chinese and international companies in relation to antitrust, sanctions, money laundering and corporate compliance issues.
    • Represented a Fortune 500 retailer in internal investigations involving potential violations of the U.S. Foreign Corrupt Practices Act by its Chinese subsidiaries.
    • Represented a U.S.-listed leading global computer software company in an internal investigation into potential violations of the U.S. Foreign Corrupt Practices Act.
    • Represented a U.S.-listed company in the medical industry in an internal investigation of a whistleblower complaint in relation to the U.S. Foreign Corrupt Practices Act and other issues.
    • Represented a U.S.-listed company in an FCPA internal investigation relating to its Chinese subsidiaries.
    • Represented various Hong Kong-listed companies in Securities and Futures Commission investigations.
    Employment
    • Advised various international companies on employment-related issues, including enforcement and application of restrictive constraints, claims for breach of employment contract and variation of the contractual terms.

Insights

News